30 participants
Phase II Efficacy Study of Repotrectinib in Frail and/or Elderly Patients With ROS1-rearranged Advanced NSCLC
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-07
- Start Date:
- 2024-10-01
- Completion:
- 2031-09-30
Conditions
- NSCLC Stage IV
- NSCLC, Stage III
Interventions
- DRUG
No Results Yet